A Study of GLB-002 in Patients With Relapsed or Refractory Non-Hodgkin Lymphomas

Clinical trial NCT06219356 · RECRUITING

Trial details

NCT number: NCT06219356
Sponsor: Hangzhou GluBio Pharmaceutical Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Non-Hodgkin Lymphoma

Start date: 2024-01-11
Primary completion: 2026-01-31
Enrollment: 110

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.